Review



hyperhidrosis disease severity scale (hdss)  (Allergan)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Allergan hyperhidrosis disease severity scale (hdss)
    Mean DLQI scores for <t>hyperhidrosis</t> relative to other skin conditions. DLQI = Dermatology Quality of Life Index.
    Hyperhidrosis Disease Severity Scale (Hdss), supplied by Allergan, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hyperhidrosis+disease+severity+scale+%28hdss%29/pmc10374185-78-6-0?v=Allergan
    Average 90 stars, based on 1 article reviews
    hyperhidrosis disease severity scale (hdss) - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact"

    Article Title: Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact

    Journal: Medicine

    doi: 10.1097/MD.0000000000032764

    Mean DLQI scores for hyperhidrosis relative to other skin conditions. DLQI = Dermatology Quality of Life Index.
    Figure Legend Snippet: Mean DLQI scores for hyperhidrosis relative to other skin conditions. DLQI = Dermatology Quality of Life Index.

    Techniques Used:

    Proportion of patients changing clothing ≥2 times per day because of excessive sweating from hyperhidrosis. * P < .001 versus placebo. OnabotA = onabotulinumtoxinA.
    Figure Legend Snippet: Proportion of patients changing clothing ≥2 times per day because of excessive sweating from hyperhidrosis. * P < .001 versus placebo. OnabotA = onabotulinumtoxinA.

    Techniques Used:

    Axillary hyperhidrosis (A) before and (B) 2 weeks after onabotulinumtoxinA treatment, documented by the Minor starch–iodine test. Adapted with permission from: Naumann M, et al.
    Figure Legend Snippet: Axillary hyperhidrosis (A) before and (B) 2 weeks after onabotulinumtoxinA treatment, documented by the Minor starch–iodine test. Adapted with permission from: Naumann M, et al.

    Techniques Used: Starch, Iodine Test

    Hyperhidrosis Disease Severity Scale (HDSS).
    Figure Legend Snippet: Hyperhidrosis Disease Severity Scale (HDSS).

    Techniques Used:

    Key outcomes in the US/Canadian study. Week 4 data figure adapted with permission from: Lowe NJ, et al. Hyperhidrosis Disease Severity Scale (My underarm sweating is: [A] never noticeable and never interferes with my daily activities; [B] tolerable but sometimes interferes with my daily activities; [C] barely tolerable and frequently interferes with my daily activities; [D] intolerable and always interferes with my daily activities). * P < .001 for both onabotulinumtoxinA doses versus placebo. † P < .01 for both onabotulinumtoxinA doses versus placebo. HDSS = Hyperhidrosis Disease Severity Scale.
    Figure Legend Snippet: Key outcomes in the US/Canadian study. Week 4 data figure adapted with permission from: Lowe NJ, et al. Hyperhidrosis Disease Severity Scale (My underarm sweating is: [A] never noticeable and never interferes with my daily activities; [B] tolerable but sometimes interferes with my daily activities; [C] barely tolerable and frequently interferes with my daily activities; [D] intolerable and always interferes with my daily activities). * P < .001 for both onabotulinumtoxinA doses versus placebo. † P < .01 for both onabotulinumtoxinA doses versus placebo. HDSS = Hyperhidrosis Disease Severity Scale.

    Techniques Used:

    Estimates of axillary hyperhidrosis prevalence in the United States. [ <xref ref-type= 11 , 24 ]" title="Estimates of axillary hyperhidrosis prevalence in the United States. [ ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Estimates of axillary hyperhidrosis prevalence in the United States. [ 11 , 24 ]

    Techniques Used:



    Similar Products

    hyperhidrosis disease severity scale (hdss)  (Allergan)
    90
    Allergan hyperhidrosis disease severity scale (hdss)
    Mean DLQI scores for <t>hyperhidrosis</t> relative to other skin conditions. DLQI = Dermatology Quality of Life Index.
    Hyperhidrosis Disease Severity Scale (Hdss), supplied by Allergan, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hyperhidrosis+disease+severity+scale+%28hdss%29/pmc10374185-78-6-0?v=Allergan
    Average 90 stars, based on 1 article reviews
    hyperhidrosis disease severity scale (hdss) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    hdss [hyperhidrosis disease severity scale]  (Anwendung GmbH)
    90
    Anwendung GmbH hdss [hyperhidrosis disease severity scale]
    Mean DLQI scores for <t>hyperhidrosis</t> relative to other skin conditions. DLQI = Dermatology Quality of Life Index.
    Hdss [Hyperhidrosis Disease Severity Scale], supplied by Anwendung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hyperhidrosis+disease+severity+scale+%28hdss%29/pm30795027-131-0-5?v=Anwendung+GmbH
    Average 90 stars, based on 1 article reviews
    hdss [hyperhidrosis disease severity scale] - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Mean DLQI scores for hyperhidrosis relative to other skin conditions. DLQI = Dermatology Quality of Life Index.

    Journal: Medicine

    Article Title: Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact

    doi: 10.1097/MD.0000000000032764

    Figure Lengend Snippet: Mean DLQI scores for hyperhidrosis relative to other skin conditions. DLQI = Dermatology Quality of Life Index.

    Article Snippet: Allergan therefore developed and validated the Hyperhidrosis Disease Severity Scale (HDSS; Table ), a 4-point scale ranging from 1 (underarm sweating is never noticeable and never interferes with daily activities) to 4 (underarm sweating is intolerable and always interferes with daily activities).

    Techniques:

    Proportion of patients changing clothing ≥2 times per day because of excessive sweating from hyperhidrosis. * P < .001 versus placebo. OnabotA = onabotulinumtoxinA.

    Journal: Medicine

    Article Title: Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact

    doi: 10.1097/MD.0000000000032764

    Figure Lengend Snippet: Proportion of patients changing clothing ≥2 times per day because of excessive sweating from hyperhidrosis. * P < .001 versus placebo. OnabotA = onabotulinumtoxinA.

    Article Snippet: Allergan therefore developed and validated the Hyperhidrosis Disease Severity Scale (HDSS; Table ), a 4-point scale ranging from 1 (underarm sweating is never noticeable and never interferes with daily activities) to 4 (underarm sweating is intolerable and always interferes with daily activities).

    Techniques:

    Axillary hyperhidrosis (A) before and (B) 2 weeks after onabotulinumtoxinA treatment, documented by the Minor starch–iodine test. Adapted with permission from: Naumann M, et al.

    Journal: Medicine

    Article Title: Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact

    doi: 10.1097/MD.0000000000032764

    Figure Lengend Snippet: Axillary hyperhidrosis (A) before and (B) 2 weeks after onabotulinumtoxinA treatment, documented by the Minor starch–iodine test. Adapted with permission from: Naumann M, et al.

    Article Snippet: Allergan therefore developed and validated the Hyperhidrosis Disease Severity Scale (HDSS; Table ), a 4-point scale ranging from 1 (underarm sweating is never noticeable and never interferes with daily activities) to 4 (underarm sweating is intolerable and always interferes with daily activities).

    Techniques: Starch, Iodine Test

    Hyperhidrosis Disease Severity Scale (HDSS).

    Journal: Medicine

    Article Title: Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact

    doi: 10.1097/MD.0000000000032764

    Figure Lengend Snippet: Hyperhidrosis Disease Severity Scale (HDSS).

    Article Snippet: Allergan therefore developed and validated the Hyperhidrosis Disease Severity Scale (HDSS; Table ), a 4-point scale ranging from 1 (underarm sweating is never noticeable and never interferes with daily activities) to 4 (underarm sweating is intolerable and always interferes with daily activities).

    Techniques:

    Key outcomes in the US/Canadian study. Week 4 data figure adapted with permission from: Lowe NJ, et al. Hyperhidrosis Disease Severity Scale (My underarm sweating is: [A] never noticeable and never interferes with my daily activities; [B] tolerable but sometimes interferes with my daily activities; [C] barely tolerable and frequently interferes with my daily activities; [D] intolerable and always interferes with my daily activities). * P < .001 for both onabotulinumtoxinA doses versus placebo. † P < .01 for both onabotulinumtoxinA doses versus placebo. HDSS = Hyperhidrosis Disease Severity Scale.

    Journal: Medicine

    Article Title: Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact

    doi: 10.1097/MD.0000000000032764

    Figure Lengend Snippet: Key outcomes in the US/Canadian study. Week 4 data figure adapted with permission from: Lowe NJ, et al. Hyperhidrosis Disease Severity Scale (My underarm sweating is: [A] never noticeable and never interferes with my daily activities; [B] tolerable but sometimes interferes with my daily activities; [C] barely tolerable and frequently interferes with my daily activities; [D] intolerable and always interferes with my daily activities). * P < .001 for both onabotulinumtoxinA doses versus placebo. † P < .01 for both onabotulinumtoxinA doses versus placebo. HDSS = Hyperhidrosis Disease Severity Scale.

    Article Snippet: Allergan therefore developed and validated the Hyperhidrosis Disease Severity Scale (HDSS; Table ), a 4-point scale ranging from 1 (underarm sweating is never noticeable and never interferes with daily activities) to 4 (underarm sweating is intolerable and always interferes with daily activities).

    Techniques:

    Estimates of axillary hyperhidrosis prevalence in the United States. [ <xref ref-type= 11 , 24 ]" width="100%" height="100%">

    Journal: Medicine

    Article Title: Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact

    doi: 10.1097/MD.0000000000032764

    Figure Lengend Snippet: Estimates of axillary hyperhidrosis prevalence in the United States. [ 11 , 24 ]

    Article Snippet: Allergan therefore developed and validated the Hyperhidrosis Disease Severity Scale (HDSS; Table ), a 4-point scale ranging from 1 (underarm sweating is never noticeable and never interferes with daily activities) to 4 (underarm sweating is intolerable and always interferes with daily activities).

    Techniques: